$OPCH
Option Care Health, Inc.

2013 Q4 Form 10-Q Financial Statement

#000101473913000011 Filed on November 12, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q3
Revenue $225.5M $190.6M $170.4M
YoY Change 24.76% 11.9% 27.3%
Cost Of Revenue $157.3M $129.0M $112.4M
YoY Change 96.13% 14.79% 40.11%
Gross Profit $68.20M $61.66M $58.00M
YoY Change 12.92% 6.29% 8.15%
Gross Profit Margin 30.24% 32.34% 34.05%
Selling, General & Admin $69.30M $56.10M $50.20M
YoY Change 131.0% 11.75% 10.57%
% of Gross Profit 101.62% 90.99% 86.55%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.900M $3.225M $2.134M
YoY Change 58.33% 51.12% 19.62%
% of Gross Profit 2.79% 5.23% 3.68%
Operating Expenses $65.80M $56.60M $51.30M
YoY Change 111.58% 10.33% 10.8%
Operating Profit $2.396M -$688.0K $3.386M
YoY Change -91.82% -120.32% -21.84%
Interest Expense -$8.000M $7.183M $6.497M
YoY Change 25.0% 10.56% -0.47%
% of Operating Profit -333.89% 191.88%
Other Income/Expense, Net
YoY Change
Pretax Income -$13.01M -$23.77M -$3.111M
YoY Change 32.77% 664.03% 41.67%
Income Tax $2.600M -$13.00K -$2.506M
% Of Pretax Income
Net Earnings -$18.56M -$34.09M -$11.54M
YoY Change -358.48% 195.48% -2205.11%
Net Earnings / Revenue -8.23% -17.88% -6.77%
Basic Earnings Per Share -$0.27 -$0.53 -$0.20
Diluted Earnings Per Share -$1.094M -$0.53 -$0.20
COMMON SHARES
Basic Shares Outstanding 68.11M shares 67.91M shares 56.64M shares
Diluted Shares Outstanding 67.91M shares 56.64M shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.000M $0.00 $67.20M
YoY Change -98.39% -100.0%
Cash & Equivalents $1.001M $0.00 $67.18M
Short-Term Investments
Other Short-Term Assets $29.40M $13.30M $8.900M
YoY Change 188.24% 49.44% -31.54%
Inventory $34.34M $30.33M $36.60M
Prepaid Expenses
Receivables $172.2M $178.5M $142.1M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $237.0M $222.1M $254.8M
YoY Change 0.65% -12.82% -3.42%
LONG-TERM ASSETS
Property, Plant & Equipment $41.18M $41.05M $21.12M
YoY Change 73.61% 94.35% -26.91%
Goodwill $571.3M $605.7M $350.6M
YoY Change 80.22% 72.75%
Intangibles $16.82M $34.09M $17.37M
YoY Change -3.57% 96.27%
Long-Term Investments $0.00 $0.00 $7.500M
YoY Change -100.0% -100.0%
Other Assets $3.733M $4.487M $2.151M
YoY Change 81.83% 108.6% -71.7%
Total Long-Term Assets $699.9M $704.2M $402.0M
YoY Change 71.99% 75.15% -2.73%
TOTAL ASSETS
Total Short-Term Assets $237.0M $222.1M $254.8M
Total Long-Term Assets $699.9M $704.2M $402.0M
Total Assets $936.9M $926.3M $656.8M
YoY Change 45.84% 41.03% -3.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $63.58M $50.28M $48.17M
YoY Change 84.61% 4.38% -35.95%
Accrued Expenses $38.50M $38.00M $49.00M
YoY Change -18.6% -22.45% -2.97%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $60.26M $35.30M $1.000M
YoY Change 6222.88% 3430.0% -98.08%
Total Short-Term Liabilities $176.3M $133.5M $130.6M
YoY Change 62.86% 2.25% -36.04%
LONG-TERM LIABILITIES
Long-Term Debt $375.3M $380.3M $225.5M
YoY Change 66.49% 68.65% -0.62%
Other Long-Term Liabilities $17.54M $30.40M $6.084M
YoY Change 252.14% 399.7% 52.1%
Total Long-Term Liabilities $392.9M $30.40M $6.084M
YoY Change 70.51% 399.7% -97.37%
TOTAL LIABILITIES
Total Short-Term Liabilities $176.3M $133.5M $130.6M
Total Long-Term Liabilities $392.9M $30.40M $6.084M
Total Liabilities $582.3M $556.0M $373.3M
YoY Change 66.86% 48.93% -16.0%
SHAREHOLDERS EQUITY
Retained Earnings -$154.7M -$136.2M -$92.26M
YoY Change 81.86% 47.6%
Common Stock $519.6M $516.8M $386.1M
YoY Change 33.65% 33.86%
Preferred Stock
YoY Change
Treasury Stock (at cost) $10.31M $10.31M $10.31M
YoY Change 0.0% 0.0%
Treasury Stock Shares 2.583M shares 2.583M shares 2.583M shares
Shareholders Equity $354.6M $370.3M $283.5M
YoY Change
Total Liabilities & Shareholders Equity $936.9M $926.3M $656.8M
YoY Change 45.84% 41.03% 0.91%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income -$18.56M -$34.09M -$11.54M
YoY Change -358.48% 195.48% -2205.11%
Depreciation, Depletion And Amortization $1.900M $3.225M $2.134M
YoY Change 58.33% 51.12% 19.62%
Cash From Operating Activities -$16.30M -$16.20M $3.700M
YoY Change -1118.75% -537.84% 311.11%
INVESTING ACTIVITIES
Capital Expenditures -$5.600M -$8.900M -$2.100M
YoY Change 7.69% 323.81% -1150.0%
Acquisitions
YoY Change
Other Investing Activities $2.100M -$212.3M -$42.00M
YoY Change -151.22% 405.48% 3400.0%
Cash From Investing Activities -$3.600M -$221.3M -$44.10M
YoY Change -61.29% 401.81% 4800.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 20.80M 155.9M -30.80M
YoY Change 700.0% -606.17%
NET CHANGE
Cash From Operating Activities -16.30M -16.20M 3.700M
Cash From Investing Activities -3.600M -221.3M -44.10M
Cash From Financing Activities 20.80M 155.9M -30.80M
Net Change In Cash 900.0K -81.60M -71.20M
YoY Change -117.65% 14.61% 8737190613577143000.0%
FREE CASH FLOW
Cash From Operating Activities -$16.30M -$16.20M $3.700M
Capital Expenditures -$5.600M -$8.900M -$2.100M
Free Cash Flow -$10.70M -$7.300M $5.800M
YoY Change -257.35% -225.86% 728.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
34438000 USD
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
50281000 USD
CY2013Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
40828000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33365000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
388798000 USD
CY2013Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
516818000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
2844000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
4801000 USD
CY2013Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
14217000 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
22212000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
662000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1410000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4801000 USD
CY2013Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1009000 USD
CY2012Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1087000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2844000 USD
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6300000 shares
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5400000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5400000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6300000 shares
CY2012Q4 us-gaap Assets
Assets
642376000 USD
CY2013Q3 us-gaap Assets
Assets
926300000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
235427000 USD
CY2013Q3 us-gaap Assets Current
AssetsCurrent
222118000 USD
CY2012Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
46708000 USD
CY2012Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
30859000 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.03
CY2013Q3 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
0 USD
CY2013Q3 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
38000 USD
CY2012Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2900000 USD
CY2013Q3 us-gaap Capital Lease Obligations
CapitalLeaseObligations
570000 USD
CY2012Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
1379000 USD
CY2013Q3 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
851000 USD
CY2013Q3 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
103000 USD
CY2013Q3 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
310000 USD
CY2013Q3 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
400000 USD
CY2013Q3 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
0 USD
CY2012Q3 us-gaap Capitalized Computer Software Amortization
CapitalizedComputerSoftwareAmortization
400000 USD
us-gaap Capitalized Computer Software Amortization
CapitalizedComputerSoftwareAmortization
1000000 USD
CY2013Q3 us-gaap Capitalized Computer Software Amortization
CapitalizedComputerSoftwareAmortization
400000 USD
us-gaap Capitalized Computer Software Amortization
CapitalizedComputerSoftwareAmortization
1000000 USD
CY2012Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
9939000 USD
CY2013Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
11255000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62101000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67182000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
67182000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-62101000 USD
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
161499000 USD
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
0 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-12866000 USD
us-gaap Cost Of Revenue
CostOfRevenue
317332000 USD
us-gaap Cost Of Revenue
CostOfRevenue
401752000 USD
CY2013Q3 us-gaap Cost Of Revenue
CostOfRevenue
140197000 USD
CY2012Q3 us-gaap Cost Of Revenue
CostOfRevenue
112361000 USD
CY2012Q3 us-gaap Cost Of Services
CostOfServices
26750000 USD
CY2013Q3 us-gaap Cost Of Services
CostOfServices
24632000 USD
us-gaap Cost Of Services
CostOfServices
77929000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-31599000 USD
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Cost Of Services
CostOfServices
84275000 USD
CY2012Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-2933000 USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59600713 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
70570520 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67988000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
57026957 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
6000 USD
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
7000 USD
CY2013Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
11623000 USD
CY2012Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
4315000 USD
CY2013Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-94000 USD
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-613000 USD
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-3082000 USD
CY2012Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-2971000 USD
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-3109000 USD
CY2013Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-669000 USD
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-1136000 USD
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-523000 USD
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-27000 USD
CY2013Q3 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-575000 USD
CY2012Q3 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-38000 USD
CY2012Q3 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
496000 USD
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1170000 USD
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
496000 USD
CY2013Q3 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
278000 USD
CY2013Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
18888000 USD
CY2012Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
2877000 USD
CY2012Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
465000 USD
CY2013Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
82000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
465000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1105000 USD
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-31000 USD
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-65000 USD
CY2013Q3 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-196000 USD
CY2012Q3 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-31000 USD
CY2013Q3 us-gaap Deferred Tax Liabilities Gross Noncurrent
DeferredTaxLiabilitiesGrossNoncurrent
11693000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Gross Noncurrent
DeferredTaxLiabilitiesGrossNoncurrent
10291000 USD
CY2013Q2 us-gaap Deposit Assets
DepositAssets
1100000 USD
us-gaap Depreciation
Depreciation
8298000 USD
us-gaap Depreciation
Depreciation
6115000 USD
CY2012Q3 us-gaap Depreciation
Depreciation
2134000 USD
CY2013Q3 us-gaap Depreciation
Depreciation
3269000 USD
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
100012000 USD
CY2012Q3 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
0 USD
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
6550000 USD
CY2013Q3 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
6550000 USD
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
7200000 USD
CY2012Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
2100000 USD
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0 USD
CY2013Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0 USD
us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
0 USD
us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
15000000 USD
CY2013Q3 us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
15000000 USD
CY2012Q3 us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
0 USD
CY2012Q2 us-gaap Disposal Group Including Discontinued Operation Goodwill
DisposalGroupIncludingDiscontinuedOperationGoodwill
11754000 USD
CY2012Q3 us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
315000 USD
us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
503000 USD
us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
30353000 USD
CY2013Q3 us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
580000 USD
CY2012Q2 us-gaap Disposal Group Including Discontinued Operation Intangible Assets Net
DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNet
2503000 USD
CY2012Q3 us-gaap Disposal Group Including Discontinued Operation Interest Expense
DisposalGroupIncludingDiscontinuedOperationInterestExpense
0 USD
us-gaap Disposal Group Including Discontinued Operation Interest Expense
DisposalGroupIncludingDiscontinuedOperationInterestExpense
900000 USD
CY2012Q2 us-gaap Disposal Group Including Discontinued Operation Inventory
DisposalGroupIncludingDiscontinuedOperationInventory
30560000 USD
CY2012Q2 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment Net
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNet
1592000 USD
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
-58000 USD
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
466829000 USD
CY2012Q3 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
289000 USD
CY2013Q3 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
-3000 USD
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.81
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
481899000 USD
CY2013Q3 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
208879000 USD
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
129089000 USD
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
143178000 USD
CY2013Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
39868000 USD
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
598683000 USD
CY2012Q3 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
170365000 USD
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.81
CY2013Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
14656000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9854000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1622000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2735000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
4966000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5571000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
33350000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
11900000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18694000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2046000 USD
CY2012Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
3219000 USD
CY2013Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
4255000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-15898000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2012Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2013Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-15898000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
350810000 USD
CY2013Q3 us-gaap Goodwill
Goodwill
605663000 USD
CY2012Q3 us-gaap Gross Profit
GrossProfit
58004000 USD
us-gaap Gross Profit
GrossProfit
164567000 USD
us-gaap Gross Profit
GrossProfit
196931000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
68682000 USD
us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
323823000 USD
us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
233057000 USD
CY2013Q3 us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
115565000 USD
CY2012Q3 us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
85611000 USD
CY2012Q3 us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
123361000 USD
us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
469594000 USD
CY2013Q3 us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
169011000 USD
us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
338721000 USD
CY2012Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
47004000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-22442000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-38229000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-605000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-6921000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3111000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-9565000 USD
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.61
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.12
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3348000 USD
CY2012Q3 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1090000 USD
CY2013Q3 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-8060000 USD
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-13391000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-38260000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-23029000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.01
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.61
CY2013Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.35
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.12
CY2013Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.35
CY2012Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.01
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-10931000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-12866000 USD
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-11645000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
64448000 USD
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.18
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.20
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.19
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
1.15
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.19
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.18
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
1.15
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.20
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-661000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-587000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2644000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-31000 USD
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2506000 USD
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
15489000 USD
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
465000 USD
CY2013Q3 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
9601000 USD
CY2012Q3 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-2484000 USD
CY2013Q3 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-37000 USD
us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
229000 USD
CY2012Q3 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
705000 USD
us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
227000 USD
us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
0 USD
CY2013Q3 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-468000 USD
CY2012Q3 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
0 USD
us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
0 USD
CY2012Q3 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
357000 USD
us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-7000 USD
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
7827000 USD
us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1861000 USD
CY2013Q3 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1634000 USD
CY2012Q3 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
6000 USD
us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
-495000 USD
CY2013Q3 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
11000 USD
us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
17000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1628000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
242000 USD
CY2012Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
5803000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-34425000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
8102000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-2164000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-1402000 USD
us-gaap Increase Decrease In Future Policy Benefit Reserves
IncreaseDecreaseInFuturePolicyBenefitReserves
-1099000 USD
us-gaap Increase Decrease In Future Policy Benefit Reserves
IncreaseDecreaseInFuturePolicyBenefitReserves
-5275000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
5737000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-3832000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-8875000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
17873000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-5212000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
5615000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-838000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4822000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
20021000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-88227000 USD
CY2013Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
15400000 USD
CY2012Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
15400000 USD
CY2013Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
34094000 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17446000 USD
us-gaap Interest Expense
InterestExpense
20168000 USD
CY2012Q3 us-gaap Interest Expense
InterestExpense
6497000 USD
us-gaap Interest Expense
InterestExpense
19705000 USD
CY2013Q3 us-gaap Interest Expense
InterestExpense
7182000 USD
us-gaap Interest Paid Net
InterestPaidNet
13961000 USD
us-gaap Interest Paid Net
InterestPaidNet
22598000 USD
CY2013Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1971000 USD
CY2013Q3 us-gaap Inventory Net
InventoryNet
30326000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
34034000 USD
CY2012Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
10042000 USD
CY2013Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
0 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
5600000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
4600000 USD
CY2013Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2000000 USD
CY2012Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1700000 USD
CY2013Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
11503000 USD
CY2012Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
7164000 USD
CY2013Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
380332000 USD
CY2013Q3 us-gaap Liabilities
Liabilities
555965000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
348967000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
642376000 USD
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
926300000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
108269000 USD
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
133538000 USD
CY2012 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
800000 USD
CY2012Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
225426000 USD
CY2012Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
953000 USD
CY2013Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
35275000 USD
CY2013Q4 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
12600000 USD
CY2013Q2 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
2300000 USD
us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
3500000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
274968000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-61284000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-298807000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
103214000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-298807000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-58285000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38262000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25252000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-25396000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
56851000 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-11536000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-34087000 USD
us-gaap Net Income Loss
NetIncomeLoss
57527000 USD
us-gaap Net Income Loss
NetIncomeLoss
-51095000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
10140000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3386000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2194000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
51000 USD
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
34866000 USD
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
2477000 USD
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
4675000 USD
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
5699000 USD
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
7138000 USD
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
8883000 USD
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
5994000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2053000 USD
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4487000 USD
CY2013Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
30402000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4981000 USD
CY2013Q3 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
57999000 USD
CY2012Q3 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
46772000 USD
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
135404000 USD
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
19929000 USD
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
5777000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
41746000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
285039000 USD
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
0 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
377283000 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
5922000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1885000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1041440000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
379896000 USD
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
0 USD
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
8509000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
399000 USD
CY2013Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
81878000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
57086000 USD
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
41050000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23721000 USD
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
166761000 USD
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
2348000 USD
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
0 USD
CY2013Q2 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-8500000 USD
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13308000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10189000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
118570000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2012Q3 us-gaap Restructuring Charges
RestructuringCharges
2321000 USD
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-136179000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-85084000 USD
us-gaap Revenues
Revenues
598683000 USD
CY2013Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3947000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
10677000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
11028000 USD
CY2012Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3440000 USD
CY2012Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
129103000 USD
CY2013Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
178484000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
364859000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1105262000 USD
CY2013Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
21000000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
3210000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
809000 USD
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
0 USD
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
237397000 USD
us-gaap Restructuring Charges
RestructuringCharges
3696000 USD
us-gaap Restructuring Charges
RestructuringCharges
3510000 USD
CY2013Q3 us-gaap Restructuring Charges
RestructuringCharges
786000 USD
CY2013Q3 us-gaap Revenues
Revenues
208879000 USD
CY2012Q3 us-gaap Revenues
Revenues
170365000 USD
us-gaap Revenues
Revenues
481899000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4398000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
7260000 USD
CY2012Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1687000 USD
CY2013Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1427000 USD
CY2013Q2 us-gaap Share Price
SharePrice
12
CY2013Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10406250 shares
CY2013Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
118600000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
293409000 USD
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
370335000 USD
CY2013Q3 us-gaap Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves
SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves
2136000 USD
CY2012Q4 us-gaap Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves
SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves
7411000 USD
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2582520 shares
CY2013Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
2582520 shares
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
10311000 USD
CY2013Q3 us-gaap Treasury Stock Value
TreasuryStockValue
10311000 USD
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2012Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2013Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63368000 shares
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56640000 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67912000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56019000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63368000 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67912000 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56640000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56019000 shares
CY2013Q3 bios Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
36073000 USD
CY2012Q4 bios Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
41491000 USD
CY2012Q3 bios Acquisition And Integration Expenses
AcquisitionAndIntegrationExpenses
998000 USD
CY2013Q3 bios Acquisition And Integration Expenses
AcquisitionAndIntegrationExpenses
4890000 USD
bios Acquisition And Integration Expenses
AcquisitionAndIntegrationExpenses
13025000 USD
bios Acquisition And Integration Expenses
AcquisitionAndIntegrationExpenses
1806000 USD
CY2013Q3 bios Adjusted Ebitda
AdjustedEbitda
19538000 USD
bios Adjusted Ebitda
AdjustedEbitda
48664000 USD
bios Adjusted Ebitda
AdjustedEbitda
59145000 USD
CY2012Q3 bios Adjusted Ebitda
AdjustedEbitda
18238000 USD
bios Amount Company May Be Required To Refund Related Directly Or Indirectly To Buyers Retention Of Certain Business After Closing
AmountCompanyMayBeRequiredToRefundRelatedDirectlyOrIndirectlyToBuyersRetentionOfCertainBusinessAfterClosing
6400000 USD
CY2012Q1 bios Amount Company Received As Result Of Agreement Which Provided That Bioscrip Ceased To Be Sole Fulfillment Pharmacy For Customers Who Came Through Drugstore Com Website
AmountCompanyReceivedAsResultOfAgreementWhichProvidedThatBioscripCeasedToBeSoleFulfillmentPharmacyForCustomersWhoCameThroughDrugstoreComWebsite
3000000 USD
bios Amounts Due To Plan Sponsor
AmountsDueToPlanSponsor
3415000 USD
bios Amounts Due To Plan Sponsor
AmountsDueToPlanSponsor
10372000 USD
CY2013Q3 bios Amounts Due To Plan Sponsors
AmountsDueToPlanSponsors
7802000 USD
CY2012Q4 bios Amounts Due To Plan Sponsors
AmountsDueToPlanSponsors
18173000 USD
bios Capital Lease Obligations Incurred To Acquire Property And Equipment
CapitalLeaseObligationsIncurredToAcquirePropertyAndEquipment
20000 USD
bios Capital Lease Obligations Incurred To Acquire Property And Equipment
CapitalLeaseObligationsIncurredToAcquirePropertyAndEquipment
0 USD
bios Cash Consideration Paid Dspharmacy
CashConsiderationPaidDspharmacy
0 USD
bios Cash Consideration Paid Dspharmacy
CashConsiderationPaidDspharmacy
-2935000 USD
CY2013Q3 bios Computer And Office Equipment Gross
ComputerAndOfficeEquipmentGross
18858000 USD
CY2012Q4 bios Computer And Office Equipment Gross
ComputerAndOfficeEquipmentGross
14443000 USD
CY2012Q2 bios Contingent Consideration Period
ContingentConsiderationPeriod
P14M
CY2012Q3 bios Disposal Group Including Discontinued Operation Impairment Costs Employee Severanceand Other Costs
DisposalGroupIncludingDiscontinuedOperationImpairmentCostsEmployeeSeveranceandOtherCosts
13032000 USD
CY2013Q3 bios Disposal Group Including Discontinued Operation Impairment Costs Employee Severanceand Other Costs
DisposalGroupIncludingDiscontinuedOperationImpairmentCostsEmployeeSeveranceandOtherCosts
0 USD
bios Disposal Group Including Discontinued Operation Impairment Costs Employee Severanceand Other Costs
DisposalGroupIncludingDiscontinuedOperationImpairmentCostsEmployeeSeveranceandOtherCosts
0 USD
bios Disposal Group Including Discontinued Operation Impairment Costs Employee Severanceand Other Costs
DisposalGroupIncludingDiscontinuedOperationImpairmentCostsEmployeeSeveranceandOtherCosts
13032000 USD
CY2012 bios Disposal Group Including Discontinued Operation Proceeds
DisposalGroupIncludingDiscontinuedOperationProceeds
173800000 USD
CY2012Q2 bios Disposal Group Including Discontinued Operations Prepaid Expenses And Other Current Assets
DisposalGroupIncludingDiscontinuedOperationsPrepaidExpensesAndOtherCurrentAssets
299000 USD
CY2013Q3 bios Duefrom Saleof Affiliate Equity Investment Noncurrent
DuefromSaleofAffiliateEquityInvestmentNoncurrent
2100000 USD
CY2013Q2 bios Employee Stock Ownership Plan Shares Registered
EmployeeStockOwnershipPlanSharesRegistered
750000 shares
CY2013Q3 bios Finite Lived Intangible Assets Amortization Expense Year Fiveand After
FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveandAfter
3800000 USD
CY2013Q3 bios Future Minimum Leases Due Thereafter
FutureMinimumLeasesDueThereafter
5994000 USD
CY2013Q3 bios Future Minimum Payments Due
FutureMinimumPaymentsDue
35717000 USD
CY2013Q3 bios Future Minimum Payments Due Current
FutureMinimumPaymentsDueCurrent
2580000 USD
CY2013Q3 bios Future Minimum Payments Due In Five Years
FutureMinimumPaymentsDueInFiveYears
4675000 USD
CY2013Q3 bios Future Minimum Payments Due In Four Years
FutureMinimumPaymentsDueInFourYears
5737000 USD
CY2013Q3 bios Future Minimum Payments Due In Three Years
FutureMinimumPaymentsDueInThreeYears
7448000 USD
CY2013Q3 bios Future Minimum Payments Due In Two Years
FutureMinimumPaymentsDueInTwoYears
9283000 USD
CY2013Q3 bios Indefinite Lived Intangible Assets Accumulated Amortization
IndefiniteLivedIntangibleAssetsAccumulatedAmortization
0 USD
CY2012Q4 bios Indefinite Lived Intangible Assets Accumulated Amortization
IndefiniteLivedIntangibleAssetsAccumulatedAmortization
0 USD
CY2013Q3 bios Indefinite Lived Intangible Assets Gross
IndefiniteLivedIntangibleAssetsGross
15400000 USD
CY2012Q4 bios Indefinite Lived Intangible Assets Gross
IndefiniteLivedIntangibleAssetsGross
15400000 USD
CY2013Q3 bios Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
14656000 USD
CY2012Q4 bios Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
9854000 USD
CY2013Q3 bios Intangible Assets Gross
IntangibleAssetsGross
48750000 USD
CY2012Q4 bios Intangible Assets Gross
IntangibleAssetsGross
27300000 USD
CY2013Q3 bios Long Term Debt And Capital Lease Obligations Total
LongTermDebtAndCapitalLeaseObligationsTotal
415607000 USD
CY2012Q4 bios Long Term Debt And Capital Lease Obligations Total
LongTermDebtAndCapitalLeaseObligationsTotal
226379000 USD
CY2013Q3 bios Medical Equipment Gross
MedicalEquipmentGross
22352000 USD
CY2012Q4 bios Medical Equipment Gross
MedicalEquipmentGross
16466000 USD
CY2013Q3 bios One Time Costs Related To Pharmacy Services Asset Sale Reserve
OneTimeCostsRelatedToPharmacyServicesAssetSaleReserve
15455000 USD
CY2012Q4 bios One Time Costs Related To Pharmacy Services Asset Sale Reserve
OneTimeCostsRelatedToPharmacyServicesAssetSaleReserve
134000 USD
bios One Time Costs Related To Pharmacy Services Asset Sale Reserve Noncash
OneTimeCostsRelatedToPharmacyServicesAssetSaleReserveNoncash
79000 USD
bios One Time Costs Related To Pharmacy Services Asset Sale Reserve Settled In Cash
OneTimeCostsRelatedToPharmacyServicesAssetSaleReserveSettledInCash
1688000 USD
bios Restructuring Charges Other Expensesand Investments
RestructuringChargesOtherExpensesandInvestments
3696000 USD
CY2013Q2 bios Proceedsfrom Issuanceof Common Stock Used To Fund Acquisition
ProceedsfromIssuanceofCommonStockUsedToFundAcquisition
61100000 USD
bios Restructuring Charges Other Expensesand Investments
RestructuringChargesOtherExpensesandInvestments
4424000 USD
CY2012Q3 bios Restructuring Charges Other Expensesand Investments
RestructuringChargesOtherExpensesandInvestments
2321000 USD
CY2013Q3 bios Restructuring Charges Other Expensesand Investments
RestructuringChargesOtherExpensesandInvestments
1409000 USD
bios Restructuring Costs Transaction Costs And Other One Time Charges As Result Of Transaction
RestructuringCostsTransactionCostsAndOtherOneTimeChargesAsResultOfTransaction
17088000 USD
bios Saleof Affiliate Equity Investment Period After Close Expectedto Receive Additional Servicesor Cash
SaleofAffiliateEquityInvestmentPeriodAfterCloseExpectedtoReceiveAdditionalServicesorCash
P2Y
CY2013Q2 bios Stock Issued During Period Shares Selling Stockholders
StockIssuedDuringPeriodSharesSellingStockholders
3968750 shares
bios Surrender Of Stock To Satisfy Minimum Tax Withholding
SurrenderOfStockToSatisfyMinimumTaxWithholding
0 USD
bios Surrender Of Stock To Satisfy Minimum Tax Withholding
SurrenderOfStockToSatisfyMinimumTaxWithholding
-174000 USD
CY2012Q2 bios Total Purchase Price At Closing Including Value Of Inventories On Hand Attributable To Operations Subject To Pharmacy Services Asset Sale
TotalPurchasePriceAtClosingIncludingValueOfInventoriesOnHandAttributableToOperationsSubjectToPharmacyServicesAssetSale
158800000 USD
CY2012Q3 bios Transitional Expenses
TransitionalExpenses
1900000 USD
bios Transitional Expenses
TransitionalExpenses
2800000 USD
CY2013Q3 bios Transitional Expenses
TransitionalExpenses
700000 USD
bios Transitional Expenses
TransitionalExpenses
2800000 USD
CY2013Q3 bios Vehicles Gross
VehiclesGross
2032000 USD
CY2012Q4 bios Vehicles Gross
VehiclesGross
1540000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001014739
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
68109366 shares
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
BioScrip, Inc.

Files In Submission

Name View Source Status
0001014739-13-000011-index-headers.html Edgar Link pending
0001014739-13-000011-index.html Edgar Link pending
0001014739-13-000011.txt Edgar Link pending
0001014739-13-000011-xbrl.zip Edgar Link pending
bios-20130930.xml Edgar Link completed
bios-20130930.xsd Edgar Link pending
bios-20130930x10q.htm Edgar Link pending
bios-20130930_cal.xml Edgar Link unprocessable
bios-20130930_def.xml Edgar Link unprocessable
bios-20130930_lab.xml Edgar Link unprocessable
bios-20130930_pre.xml Edgar Link unprocessable
bios-ex311x20130930.htm Edgar Link pending
bios-ex312x20130930.htm Edgar Link pending
bios-ex321x20130930.htm Edgar Link pending
bios-ex322x20130930.htm Edgar Link pending
bioscriplogoa01a01a01.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending